Deloitte Belgium recently published the results of its analysis about the Belgian BioPharma industry. Authors conclude, “Belgium has the opportunity to become the European leader in life sciences and particularly in the biopharmaceutical sector.”
Further this publication, ‘New European Economy‘ had a conversation with our Life Sciences Expert, Dr. Philippe Janssens de Varebeke (photo) and the Communication & International Relations Director of Biowin, Frédéric Druck.
They listed the assets of Wallonia such as R&D incentives, its strategic location at the heart of Europe, the availability of bio-incubators or the collaboration network linking universities, research centers and companies.
Discover why Wallonia is definitively the place to be in innovation by reading the complete article!